GO:0019058 | viral life cycle | 3.51e-09 | 3.43e-05 | 6.120 | 5 | 8 | 78 |
GO:0022627 | cytosolic small ribosomal subunit | 9.02e-09 | 8.81e-05 | 7.177 | 4 | 6 | 30 |
GO:0006413 | translational initiation | 1.18e-08 | 1.15e-04 | 5.776 | 5 | 12 | 99 |
GO:0015935 | small ribosomal subunit | 1.19e-07 | 1.16e-03 | 8.083 | 3 | 4 | 12 |
GO:0019083 | viral transcription | 1.70e-07 | 1.66e-03 | 6.153 | 4 | 7 | 61 |
GO:0006415 | translational termination | 1.93e-07 | 1.89e-03 | 6.106 | 4 | 7 | 63 |
GO:0006414 | translational elongation | 2.80e-07 | 2.74e-03 | 5.975 | 4 | 7 | 69 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 4.37e-07 | 4.27e-03 | 5.817 | 4 | 7 | 77 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.21e-07 | 6.07e-03 | 5.691 | 4 | 7 | 84 |
GO:0044822 | poly(A) RNA binding | 7.45e-07 | 7.27e-03 | 3.249 | 7 | 25 | 799 |
GO:0003735 | structural constituent of ribosome | 1.77e-06 | 1.73e-02 | 5.315 | 4 | 8 | 109 |
GO:0016071 | mRNA metabolic process | 1.04e-05 | 1.02e-01 | 4.674 | 4 | 11 | 170 |
GO:0006412 | translation | 1.25e-05 | 1.22e-01 | 4.608 | 4 | 13 | 178 |
GO:0016070 | RNA metabolic process | 1.55e-05 | 1.52e-01 | 4.529 | 4 | 11 | 188 |
GO:0075733 | intracellular transport of virus | 1.58e-05 | 1.54e-01 | 8.276 | 2 | 2 | 7 |
GO:0016032 | viral process | 1.72e-05 | 1.68e-01 | 3.664 | 5 | 13 | 428 |
GO:0006364 | rRNA processing | 2.52e-05 | 2.46e-01 | 5.602 | 3 | 5 | 67 |
GO:0042274 | ribosomal small subunit biogenesis | 4.14e-05 | 4.04e-01 | 7.624 | 2 | 3 | 11 |
GO:0010467 | gene expression | 5.08e-05 | 4.96e-01 | 3.342 | 5 | 17 | 535 |
GO:0044267 | cellular protein metabolic process | 1.81e-04 | 1.00e+00 | 3.624 | 4 | 13 | 352 |
GO:0016020 | membrane | 2.12e-04 | 1.00e+00 | 2.431 | 6 | 25 | 1207 |
GO:0002183 | cytoplasmic translational initiation | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0005829 | cytosol | 1.88e-03 | 1.00e+00 | 1.865 | 6 | 33 | 1787 |
GO:0000056 | ribosomal small subunit export from nucleus | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0070545 | PeBoW complex | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0030687 | preribosome, large subunit precursor | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0000055 | ribosomal large subunit export from nucleus | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 2 | 4 |
GO:0019082 | viral protein processing | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0000028 | ribosomal small subunit assembly | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 3 | 5 |
GO:0002309 | T cell proliferation involved in immune response | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0051347 | positive regulation of transferase activity | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0005915 | zonula adherens | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 6 |
GO:0000082 | G1/S transition of mitotic cell cycle | 5.52e-03 | 1.00e+00 | 4.118 | 2 | 6 | 125 |
GO:0005654 | nucleoplasm | 5.61e-03 | 1.00e+00 | 2.309 | 4 | 16 | 876 |
GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0019068 | virion assembly | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0031929 | TOR signaling | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 9 |
GO:0032479 | regulation of type I interferon production | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 9 |
GO:0070062 | extracellular vesicular exosome | 9.25e-03 | 1.00e+00 | 1.725 | 5 | 28 | 1641 |
GO:0007067 | mitotic nuclear division | 9.45e-03 | 1.00e+00 | 3.717 | 2 | 5 | 165 |
GO:0042273 | ribosomal large subunit biogenesis | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0033365 | protein localization to organelle | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0016282 | eukaryotic 43S preinitiation complex | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0033290 | eukaryotic 48S preinitiation complex | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0031369 | translation initiation factor binding | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0048821 | erythrocyte development | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0017134 | fibroblast growth factor binding | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0006259 | DNA metabolic process | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 14 |
GO:0001731 | formation of translation preinitiation complex | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 14 |
GO:0005978 | glycogen biosynthetic process | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 15 |
GO:0043065 | positive regulation of apoptotic process | 1.39e-02 | 1.00e+00 | 3.425 | 2 | 3 | 202 |
GO:0007220 | Notch receptor processing | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0000793 | condensed chromosome | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 17 |
GO:0043021 | ribonucleoprotein complex binding | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 17 |
GO:0007369 | gastrulation | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 17 |
GO:0007052 | mitotic spindle organization | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 17 |
GO:0006611 | protein export from nucleus | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0005844 | polysome | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 4 | 19 |
GO:0019901 | protein kinase binding | 1.81e-02 | 1.00e+00 | 3.225 | 2 | 8 | 232 |
GO:0045296 | cadherin binding | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 20 |
GO:0032480 | negative regulation of type I interferon production | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 20 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 22 |
GO:0007286 | spermatid development | 2.10e-02 | 1.00e+00 | 5.560 | 1 | 1 | 23 |
GO:0007093 | mitotic cell cycle checkpoint | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0001890 | placenta development | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 26 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 2 | 26 |
GO:0033077 | T cell differentiation in thymus | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 26 |
GO:0034332 | adherens junction organization | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 3 | 28 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 28 |
GO:0016197 | endosomal transport | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 28 |
GO:0005925 | focal adhesion | 2.62e-02 | 1.00e+00 | 2.944 | 2 | 12 | 282 |
GO:0006446 | regulation of translational initiation | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 29 |
GO:0050681 | androgen receptor binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 30 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.82e-02 | 1.00e+00 | 5.129 | 1 | 1 | 31 |
GO:0019003 | GDP binding | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 34 |
GO:0032092 | positive regulation of protein binding | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 3 | 35 |
GO:0044297 | cell body | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 1 | 35 |
GO:0030666 | endocytic vesicle membrane | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 36 |
GO:0043066 | negative regulation of apoptotic process | 3.35e-02 | 1.00e+00 | 2.753 | 2 | 6 | 322 |
GO:0003743 | translation initiation factor activity | 3.36e-02 | 1.00e+00 | 4.874 | 1 | 5 | 37 |
GO:0005515 | protein binding | 3.44e-02 | 1.00e+00 | 0.881 | 7 | 50 | 4124 |
GO:0051403 | stress-activated MAPK cascade | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 2 | 42 |
GO:0045216 | cell-cell junction organization | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 2 | 44 |
GO:0032481 | positive regulation of type I interferon production | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 1 | 48 |
GO:0034146 | toll-like receptor 5 signaling pathway | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 2 | 50 |
GO:0034166 | toll-like receptor 10 signaling pathway | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 2 | 50 |
GO:0043197 | dendritic spine | 4.61e-02 | 1.00e+00 | 4.411 | 1 | 2 | 51 |
GO:0005643 | nuclear pore | 4.61e-02 | 1.00e+00 | 4.411 | 1 | 1 | 51 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 3 | 52 |
GO:0034329 | cell junction assembly | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 2 | 53 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 1 | 53 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 3 | 53 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0034162 | toll-like receptor 9 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0034134 | toll-like receptor 2 signaling pathway | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 2 | 56 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 3 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 5.13e-02 | 1.00e+00 | 4.251 | 1 | 3 | 57 |
GO:0003729 | mRNA binding | 5.13e-02 | 1.00e+00 | 4.251 | 1 | 1 | 57 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 5.13e-02 | 1.00e+00 | 4.251 | 1 | 2 | 57 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 2 | 58 |
GO:0034138 | toll-like receptor 3 signaling pathway | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 2 | 59 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 3 | 59 |
GO:0000785 | chromatin | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 2 | 59 |
GO:0042593 | glucose homeostasis | 5.40e-02 | 1.00e+00 | 4.177 | 1 | 1 | 60 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.40e-02 | 1.00e+00 | 4.177 | 1 | 3 | 60 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 2 | 61 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 3 | 61 |
GO:0016337 | single organismal cell-cell adhesion | 5.57e-02 | 1.00e+00 | 4.129 | 1 | 1 | 62 |
GO:0000187 | activation of MAPK activity | 5.66e-02 | 1.00e+00 | 4.106 | 1 | 2 | 63 |
GO:0042470 | melanosome | 5.75e-02 | 1.00e+00 | 4.083 | 1 | 2 | 64 |
GO:0030426 | growth cone | 5.75e-02 | 1.00e+00 | 4.083 | 1 | 3 | 64 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.84e-02 | 1.00e+00 | 4.061 | 1 | 3 | 65 |
GO:0050852 | T cell receptor signaling pathway | 6.10e-02 | 1.00e+00 | 3.996 | 1 | 1 | 68 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 4 | 70 |
GO:0030496 | midbody | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 3 | 73 |
GO:0051726 | regulation of cell cycle | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 1 | 73 |
GO:0034142 | toll-like receptor 4 signaling pathway | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 2 | 73 |
GO:0071456 | cellular response to hypoxia | 6.79e-02 | 1.00e+00 | 3.836 | 1 | 1 | 76 |
GO:0006006 | glucose metabolic process | 7.14e-02 | 1.00e+00 | 3.762 | 1 | 2 | 80 |
GO:0030529 | ribonucleoprotein complex | 7.31e-02 | 1.00e+00 | 3.726 | 1 | 3 | 82 |
GO:0097190 | apoptotic signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 1 | 83 |
GO:0045202 | synapse | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 1 | 83 |
GO:0002224 | toll-like receptor signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 2 | 83 |
GO:0016055 | Wnt signaling pathway | 7.74e-02 | 1.00e+00 | 3.641 | 1 | 2 | 87 |
GO:0030027 | lamellipodium | 7.83e-02 | 1.00e+00 | 3.624 | 1 | 3 | 88 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 7.91e-02 | 1.00e+00 | 3.608 | 1 | 1 | 89 |
GO:0061024 | membrane organization | 7.91e-02 | 1.00e+00 | 3.608 | 1 | 3 | 89 |
GO:0000209 | protein polyubiquitination | 8.17e-02 | 1.00e+00 | 3.560 | 1 | 3 | 92 |
GO:0007219 | Notch signaling pathway | 8.43e-02 | 1.00e+00 | 3.514 | 1 | 2 | 95 |
GO:0034220 | ion transmembrane transport | 8.51e-02 | 1.00e+00 | 3.499 | 1 | 1 | 96 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 3 | 97 |
GO:0008286 | insulin receptor signaling pathway | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 2 | 97 |
GO:0010008 | endosome membrane | 9.02e-02 | 1.00e+00 | 3.411 | 1 | 1 | 102 |
GO:0005730 | nucleolus | 9.11e-02 | 1.00e+00 | 1.419 | 3 | 21 | 1217 |
GO:0005911 | cell-cell junction | 9.19e-02 | 1.00e+00 | 3.383 | 1 | 2 | 104 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 9.44e-02 | 1.00e+00 | 3.342 | 1 | 2 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 9.53e-02 | 1.00e+00 | 3.329 | 1 | 1 | 108 |
GO:0042981 | regulation of apoptotic process | 9.87e-02 | 1.00e+00 | 3.276 | 1 | 4 | 112 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.251 | 1 | 1 | 114 |
GO:0007420 | brain development | 1.05e-01 | 1.00e+00 | 3.189 | 1 | 2 | 119 |
GO:0003924 | GTPase activity | 1.05e-01 | 1.00e+00 | 3.189 | 1 | 3 | 119 |
GO:0006184 | GTP catabolic process | 1.14e-01 | 1.00e+00 | 3.061 | 1 | 3 | 130 |
GO:0019904 | protein domain specific binding | 1.14e-01 | 1.00e+00 | 3.061 | 1 | 1 | 130 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.15e-01 | 1.00e+00 | 3.039 | 1 | 1 | 132 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.24e-01 | 1.00e+00 | 2.934 | 1 | 3 | 142 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.39e-01 | 1.00e+00 | 2.753 | 1 | 3 | 161 |
GO:0030425 | dendrite | 1.43e-01 | 1.00e+00 | 2.708 | 1 | 3 | 166 |
GO:0019221 | cytokine-mediated signaling pathway | 1.48e-01 | 1.00e+00 | 2.657 | 1 | 4 | 172 |
GO:0007264 | small GTPase mediated signal transduction | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 4 | 174 |
GO:0005102 | receptor binding | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 1 | 174 |
GO:0003713 | transcription coactivator activity | 1.57e-01 | 1.00e+00 | 2.560 | 1 | 3 | 184 |
GO:0005975 | carbohydrate metabolic process | 1.59e-01 | 1.00e+00 | 2.544 | 1 | 1 | 186 |
GO:0005575 | cellular_component | 1.60e-01 | 1.00e+00 | 2.537 | 1 | 2 | 187 |
GO:0005525 | GTP binding | 1.68e-01 | 1.00e+00 | 2.461 | 1 | 3 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.69e-01 | 1.00e+00 | 2.447 | 1 | 2 | 199 |
GO:0006281 | DNA repair | 1.72e-01 | 1.00e+00 | 2.418 | 1 | 2 | 203 |
GO:0019899 | enzyme binding | 1.78e-01 | 1.00e+00 | 2.369 | 1 | 3 | 210 |
GO:0044281 | small molecule metabolic process | 1.79e-01 | 1.00e+00 | 1.362 | 2 | 8 | 844 |
GO:0008283 | cell proliferation | 2.00e-01 | 1.00e+00 | 2.183 | 1 | 1 | 239 |
GO:0005737 | cytoplasm | 2.04e-01 | 1.00e+00 | 0.721 | 4 | 39 | 2633 |
GO:0007155 | cell adhesion | 2.04e-01 | 1.00e+00 | 2.153 | 1 | 2 | 244 |
GO:0003723 | RNA binding | 2.06e-01 | 1.00e+00 | 2.135 | 1 | 6 | 247 |
GO:0003682 | chromatin binding | 2.10e-01 | 1.00e+00 | 2.106 | 1 | 3 | 252 |
GO:0008150 | biological_process | 2.23e-01 | 1.00e+00 | 2.007 | 1 | 2 | 270 |
GO:0000278 | mitotic cell cycle | 2.55e-01 | 1.00e+00 | 1.789 | 1 | 9 | 314 |
GO:0006351 | transcription, DNA-templated | 2.61e-01 | 1.00e+00 | 1.012 | 2 | 15 | 1076 |
GO:0055085 | transmembrane transport | 2.66e-01 | 1.00e+00 | 1.722 | 1 | 1 | 329 |
GO:0048471 | perinuclear region of cytoplasm | 2.76e-01 | 1.00e+00 | 1.657 | 1 | 7 | 344 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.98e-01 | 1.00e+00 | 1.525 | 1 | 6 | 377 |
GO:0006915 | apoptotic process | 3.21e-01 | 1.00e+00 | 1.400 | 1 | 4 | 411 |
GO:0045087 | innate immune response | 3.47e-01 | 1.00e+00 | 1.263 | 1 | 6 | 452 |
GO:0005634 | nucleus | 3.47e-01 | 1.00e+00 | 0.419 | 4 | 40 | 3246 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.50e-01 | 1.00e+00 | 1.251 | 1 | 6 | 456 |
GO:0007165 | signal transduction | 4.45e-01 | 1.00e+00 | 0.812 | 1 | 5 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.59e-01 | 1.00e+00 | 0.753 | 1 | 8 | 644 |
GO:0006355 | regulation of transcription, DNA-templated | 4.96e-01 | 1.00e+00 | 0.602 | 1 | 9 | 715 |
GO:0005886 | plasma membrane | 5.10e-01 | 1.00e+00 | 0.283 | 2 | 13 | 1784 |
GO:0046872 | metal ion binding | 5.96e-01 | 1.00e+00 | 0.216 | 1 | 10 | 934 |